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ABSTRACT 
Objective: The platelet-rich fibrin matrix (PRFM) is condensed platelet-rich plasma (PRP) and should possess a comparable biomechanical property to the 
transplanted sites, for them to be physiologically functional. The aim of this study was to investigate the effect of human bone marrow mesenchymal stem 
cells (hBM-MSC) or human umbilical cord mesenchymal stem cells (hUC-MSC) on the biomechanical properties of PRFM.  
Methods: PRFM was prepared by the gelation of PRP using 25 mmol CaCl2. The resulting coin-shaped PRFM pellets, 5 cm in diameter and 300 μm 
thick, were directly seeded with hUC-MSC or hBM-MSC at 2,000 cells cm-2, followed by 24 h incubation at 37 °C in 5% (v/v) CO2 in air. The samples 
were then observed by scanning electron microscopy to determine the morphology of the matrix surface. The PRFM biomechanical properties were 
determined at a 10 mm. min-1failure rate using an MCT 2150 universal testing machine (AandD Co. LTD).  
Results: SEM imaging of the surface of the PRFM seeded with hBM-MSC and hUC-MSC showed a cloudy layer that thickened over time. The elastin 
slope of the PRFM was significantly improved after seeding with hBM-MSC and hUC-MSC when compared with unseeded PRFM (p<0.002, 
R2=0.983). Both cell types elicited similar biomechanical effects (p=0.99).  
Conclusion: PRFM seeded with hBM-MSC or hUC-MSC showed significantly increased elasticity. 
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Wound healing after open injury or surgical procedures is 
challenging, and many materials and techniques have been 
evaluated for their ability to enhance and accelerate complete 
healing [1]. Normally, fibrin clot is formed in an open wound. It is 
highly elastic and viscous to stop bleeding and maintains hemostasis 
by forming a mesh that traps platelets [2].  
Platelets are rich in growth factors, including platelet-derived 
growth factor (PDGF), transforming growth factor (TGF-b), vascular 
endothelial growth factor (VEGF), basic fibroblast growth factor 
(bFGF) and insulin-like growth factor (IGF) [3, 4]. In addition, 
platelets release coagulation factors, serotonin, histamine, 
endostatin and hydrolytic enzymes [4]. Platelets can also be used to 
isolate a platelet-rich fibrin matrix (PRFM), a second-generation 
platelet fraction derived from platelet-rich plasma (PRP) obtained 
by centrifugation of whole blood. The PRP contains a 6-to 8-fold 
higher growth factor concentration than whole blood and can form 
the PRFM fibrin network following the addition of CaCl2 [5]. The 
growth factors in the PRFM are released slowly between 7 and 14 d.  
PRFM is used across the globe in various procedures, including 
orthopedic, cardiothoracic, vascular, general, and plastic surgeries. PRFM 
serves many different clinical needs due to its favorable promotion of 
healing, simple processing and ease of suturing to surrounding tissues. 
The natural fibrin framework in PRFM is thought to protect the growth 
factors from proteolysis. For clinical use, autologous sources for PRP are 
favored to eliminate disease transmission from donors. Naturally, the 
transplanted matrix will be invaded by the surrounding cells. While 
matrix stiffness is very important for its application that dictates the 
choice of biomaterial to replace a given tissue, nonetheless, until 
recently, no study has explored the biomechanical properties of PRFM 
after infiltrated with cells.  
Mechanical forces are important drivers of cellular growth and 
development, but mechanical overload leads to tissue injury [6]. A 
mechanical force or load that causes a material to change its shape is 
termed mechanical stress, symbolized by the Greek letter sigma (σ), 
and is defined as the force per unit area within a material (σ = F/A). 
Mechanical stress is similar to the concept of pressure and has the 
same units (N. m-2), where one N. m-2 is equal to one Pascal (Pa) of 
stress or pressure.  
PRFM, once fully polymerized, is quite stiff, with an elastic modulus 
of 937.3±314.6 kPa, stress at break value of 1476.0±526.3kPa, and 
an elongation at break value of 146.3±33.8%, as cited by Lucarelli 
and colleagues [7]. These values represent a stiffness equivalent to 
about half that of intact human skin [8]. Human BM-MSC seeded on 
decellularized tendon had increased matrix ultimate tensile stress 
after 7 d incubation with 6% strain [9]. The aim of the present study 
was to investigate the PRFM biomechanics, including the elastic 
modulus, ultimate tensile stress and ultimate tensile strain, before 
and after incubation of prepared PRFM with human bone marrow 
mesenchymal stem cells (hBM-MSC) or human umbilical cord 
mesenchymal stem cells (hUC-MSC). 
MATERIALS AND METHODS 
Upon receipt of ethical approval (no 78/UN2. F1. D/PA/PPM. 
SIPP.00.02/2018), four blood donors were screened for human 
immunodeficiency virus [10], hepatitis B, hepatitis C and 
cytomegalovirus infections. All four donors provided signed 
informed consent for participation in the study. Peripheral blood 
samples (8 ml) were withdrawn from each donor for the 
preparation of PRFM. 
Matrix preparation  
Platelet-rich plasma was isolated using RegenKit®-BCT (Regenlab), 
followed the manufacturer’s instructions. Briefly, the 8 ml of 
peripheral blood in the collection tube was centrifuged at 1500 g for 
10 min, and the resultant plasma supernatant and platelet sediment 
were inverted and mixed 10 times. A 7 ml volume was removed, 
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placed in a sterile 100 ml flask (Falcon Biologics), and sterile 25 
mmol CaCl2 was added to gel the PRP. The sample was then 
centrifuged at 3500g for 10 min to form a coin-shaped PRFM pellet 
about 5 cm in diameter and 300–400 μm thick. Each PRFM was cut 
in half, and each half was placed into a well of a 6-well plate. Eight 6-
well plates were prepared: four for hUC-MSC and four for hBM-MSC. 
Each plate group was labelled for each day of validation (Day 1, Day 
5, Day 10 and Day 13). Each plate had three wells with seeded PRFM 
and one well for an unseeded PRFM control. A separate well was 
used as a cell culture control (cells only) and another well for a 
culture medium control (culture medium only).  
Preparation of the cells  
Human UC-MSCs and the hBM-MSCs were obtained from the Stem 
Cells and Tissue Engineering Department in our university. The hUC-
MSC were obtained at passage 2, while the hBM-MSC were at passage 
1. Both hBM-MSC and hUC-MSC expressed CD 73, CD 90 and CD 105, 
but did not express Lin. Both cell types were expanded in alpha-
modified Eagle’s medium (α-MEM) (Gibco, Germany), supplemented 
with 100 U ml-1penicillin/streptomycin (Hybri-Max™, Sigma, 
Germany), 2 mmol L-glutamine (Gibco, Germany), 1% (v/v) 
amphotericin B (Gibco, Germany), 1% (v/v) heparin (Sigma, Germany) 
and 10% (v/v) platelet-rich plasma (PRP) by incubation at 37 °C in 5% 
(v/v) CO2 in air. The culture medium was refreshed every three days. 
The cells were passaged at 85% to 90% confluence, trypsinised using 
0.25% trypsin in 1 mmol EDTA (Invitrogen, Karlsruhe, Germany) and 
then re-plated at the density of 2,500 cells cm2. Cells were expanded 
from passage 2 to 4. 
Seeding preparation 
The matrix for seeding was preconditioned overnight and then directly 
seeded as described previously [11] with hBM-MSC or hUC-MSC at a 
seeding density of 2,000 cells cm-2 in 100 µl culture medium. The cells 
were left for 2 h and then then flooded with 3 ml culture medium and 
incubated at 37 °C in 5% (v/v) CO2 in air for 24 h.  
At the end of each incubation day, each specimen was cut into four 
pieces. The sample for biomechanical testing was shaped into a 5 
mm wide × 20 mm long rectangle, placed on sterile filter paper 
soaked in PBS and tested within 2 h. The sample for SEM was treated 
as described elsewhere. Briefly, the specimen was cut into a 5 × 5 
mm square (n=3), soaked in 3% glutaraldehyde in phosphate-
buffered saline (PBS) for 2 h at 4 °C, followed by 20 min PBS washes 
at 4 °C and post fixing in 2% osmium tetroxide in PBS. After 
dehydration in a graded ethanol series at 4 °C, the specimen was 
mounted and coated with a gold/palladium alloy [12]. 
Sample analysis 
Specimens prepared for SEM were cut into 5 × 5 mm2 pieces, soaked in 
2.5% (v/v) glutaraldehyde (Sigma, Germany) in PBS for 2 h, followed 
by PBS washes (3 times, 20 min each). The samples were then fixed in 
2% osmium tetroxide in PBS, washed again with PBS, and dehydrated 
in a graded ethanol series at 10 min steps at 4 °C. The SEM specimens 
were mounted with graphite, coated with gold/palladium alloy and 
visualized using an LS2 h M SEM microscope.  
A Dynatron USM-500 N load cell (AandD Co. Ltd, Switzerland) and an 
MCT 2150 testing bench were used to measure the PRFM 
biomechanical properties after 24 h incubation with and without 
seeding with hBM-MSC and hUC-MSC (n=3); the samples without 
seeded cells were used as a control. Samples were prepared as 3 cm 
(length) × 5 mm (width) rectangles measured using Vernier callipers 
(Mitutuyo, Japan). They were placed on filter paper wetted with PBS 
and tested within 2 h. Each specimen was fixed onto the grips, with 
linen placed between the grips to protect the samples from being cut 
during the test. The failure rate was set at 10 mm min-1. Only samples 
with a failure at the mid-point were included in calculations.  
Data analysis 
Raw data recorded from the Dynatron USM, with units of force (N), 
extension (mm) and time (s), were exported to Microsoft Excel 
(version 2013, Microsoft Corporation). The data were then 
converted to engineering stress (σ) and engineering strain (ɛ) 
responses of each sample by normalizing the initial sample 
dimensions. The calculation was performed manually as follows:  
The engineering strain (ɛ) was the percentage of the sample 
elongation (Δl) divided by the original sample (gauge) length (the 
sum of (l) and elongation (Δl)):  
Engineering strain (ℰ) =  
Δl (mm)
l (mm) + Δl (mm) 
 
The stress-strain value was plotted as the stress-strain slope (fig. 1), 
and the behavior of each specimen was characterized using five 
parameters: ultimate tensile strength (UTStress) (σfail), ultimate tensile 
strain (UTStrain) (ɛfail), elastin phase slope (Eelas), collagen phase slope 
(Ecoll) and the relaxation modulus (Young’s modulus, E(t)).  
The UTStress (σUTS) was determined as the initial point of the sample 
to reach the highest stress value, and the UTStrain (ɛUTS) was 
determined as the strain value at which the sample began to fail. The 
collagen phase slope (Ecoll) was determined by fitting a linear trend 
line between two points selected manually in the linear part of the 
curve between the initial toe of the curve and the yield point of the 
failure region. The elastin phase slope was determined by the area 
underneath the stress strain curve, up to a strain limit of 0.05 
because the sample size was relatively small. This limit for fascicles 
was similar to the value cited by others. The strain limit at 0.05 was 
obtained and the elastin slope was achieved by integrating the strain 
between zero and 0.05 to determine the area. The Young’s modulus 
E(t) was calculated using the following equation:  
E(t) =  
Engineering Stress (σ) (MPa)
Engineering Strain (ℰ)
  
Where   was the engineering stress and the ℰ was the engineering 
strain, as stated above. The data for the decellularized and the native 
tendon specimens were analyzed using two-sample Student’s t-tests 
to compare the two means of each biomechanical parameter (the 
variances of each group assumed homoscedasticity, as 
heteroscedastic has not affected testing sensitivity when testing an 
equal sample size). Data are presented as the mean (n=6)±95% C. I. 
 
Fig. 1: Stress-strain curve of a native tendon. (A) The stress-strain slope with the biomechanical parameters. (B) The toe region 
highlighted from the whole stress-strain curve 
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Fig. 2: Platelet-rich fibrin matrix (PRFM), (A) macroscopic, with a coin shape, prepared immediately before seeding with stem cells. (B) 
The SEM analysis (fig. 3) revealed a layer of cells on the surface after 
the 24 h incubation. This layer thickened as the incubation days 
progressed and eventually fully coated the matrix. This coating was 
 
Fig. 3: Scanning electron microscopy images of the platelet
MSC and (D, F, H, J) hUC-MSC. (C, D) Day 1, (E, F) Day 5, (G, H) Day 10 and (I, J) Day 13 incubation. Images were captured using LSM 800
Sandora et al. 
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observed with both hBM-MSC and hUC
between the two groups. By contrast, the SEM images of the 
unseeded matrix showed fibers aligned across the matrix.
-rich fibrin matrix (PRFM) (A, B) and PRFM after seeded with 
scale bars are indicated in each image 
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The biomechanical analysis of the PRFM with and without cells is 
summarized in table 1. As shown in fig. 4, the elastin slope was 
significantly improved by seeding the PRFM with hBM-MSC or hUC-
MSC (p<0.01). The Young’s modulus was two-fold higher for the PRFM 
seeded with hBM-MSC than with hUC-MSC or for the unseeded PRFM 
control. The Young’s modulus was similar for the PRFM seeded with 
hUC-MSC and the unseeded control. No differences were noted among 












Fig. 4: Biomechanical analysis of PRFM only and PRFM after seeding with hBM-MSC and hUC-MSC for 24 h. (A) Ultimate tensile stress, (B) 
Young’s modulus, (C) Ultimate tensile strain, (D) collagen slope, and (E) elastin slope. Data were analysed using one-way ANOVA, and 
differentiated using Tukey analysis; a p value<0.05 was considered statistically significant 
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Table 1: Distribution of biomechanical properties of PRFM before and after seeding with UC-MSC and BM-MSC, Data are presented as 
mean (n=3)±95% C. l. 
Biomechanical properties PRFM hBM-MSC/PRFM hUC-MSC/PRFM 
Elastin slope (MPa) 1.3±1.99 297.18±51.13 308.13±60.28 
Collagen/Ecoll  54.79±50.37 107.87±49.9 41.934±31.33 
PSD (MPa) -17.25±124.7 1246.54±2777.72 2.12±41.55 
σ UTStress (MPa) 4.97±2.798 7.1±3.06 5.48±1.96 
ɛ UTStrain (%) 0.106±0.067 0.06±0.04 0.12±0.05 
Young Modulus (MPa) 57.79±60.92 120.29±42.46 47.45±29.29 
 
DISCUSSION 
PRFM consists of bundles of monomeric fibrin that are able to undergo 
appreciable extension [2, 13]. Its biomechanical properties are 
determined by the number of fibre monomers and how they are 
braided together [2]. The mechanical behavior of the entire fibrin gel is 
determined by the number and packing arrangements of double-
stranded half-staggered protofibrils that allow orientation, stretching, 
bending and buckling [14]. However, many studies of fibrin matrix 
(PRFM) biomechanics have reported a weak capacity. As many studies 
showed cells improved matrix biomechanical properties; therefore, 
the focus of the present study was to investigate the biomechanical 
properties of PRFM before and after incubation with MSC.  
Cell populations in a scaffold are essential for the process of scaffold 
morphogenesis, tissue matrix turnover and the wound healing 
process [15, 16]. In the present study, hBM-MSC were used, as these 
cells have been reported to contribute to the healing process, 
especially in tendon repair. The hUC-MSC was also studied because 
they have potential future uses in wound healing. The hUC-MSC are 
known to release of growth differentiation factor GDF-11, which 
induces human dermal fibroblast proliferation, migration, and 
extracellular matrix (ECM) production [17]. The hUC-MSC are also 
reported to differentiate into hepatocytes, as indicated by their 
expression of the albumin gene after 14 d of incubation with 
hepatocyte growth factor (HGF) and fibroblast growth factor 4 (FGF-
4) [18]. Another study has also reported that granules of fibrin 
matrix improved the re-implantation of avulsed incisors in dogs 
after the incisor was overlaid with the granules and periodontal 
ligament stem cells. The periodontal area showed low inflammation 
and the layer formed periodontal-like tissues [19]. 
In the present in vitro study, PRFM was degraded after 5 d of 
incubation with cells, but it had retracted only by half after 24 h. By 
contrast, the unseeded control PRFM was no longer identifiable in the 
plate after 3 d of incubation. This degradation of PRFM may have been 
due to the fibrinolysis process [20], which can be blocked by adding a 
sealant agent, such as aprotinin, tranexamic acid [21], or human 
Kunitz-type proteinase inhibitor, to the fibrin matrix [22]. The Kunitz-
type proteinase is superior to aprotinin as it is derived from human 
sources and can improve the fibrin matrix longevity by up to 50% 
through a 10-fold inhibition of plasmin-mediated fibrinolysis [22]. 
Improvements in PRFM durability may be required in future studies. 
PRFM is a weak biomaterial that degrades in a fast rate. In the 
present study, the PRFM after seeded with cells had contracted up to 
70% of their original size after 5 d incubation and faded after 10 d, 
suspected they had been fully degraded. Therefore, this study had no 
biomechanical analyses conducted on the Day 5, 10 and 13 samples 
in the present study, as the sample size of the Day 5 were 
insufficient, and the Day 10 or the Day 13 samples had completely 
diminished. In addition, only the 24 h samples had sufficient 
retention of their shape and size to allow mounting in the grips for 
biomechanical testing. Other biomechanical analyses using the 
rheology test would be more sensitive for investigating gel 
formation, as it able to determine the characteristics of a single fibre.  
The culture of the PRFM with h-BM-MSC and hUC-MSC significantly 
improved the PRFM elastin slope (297.18±51.13 MPa and 
308.13±60.28 MPa, respectively) when compared with the unseeded 
PRFM control (1.3±1.99 MPa; p=0.003). No differences were found 
between the two MSC types (p=0.99). The elastin slope showed a 
significant increase after incubation with cells; this might be due to cell 
to cell interactions through the cytoskeleton [23]. A previous study on 
keratinocytes co-cultured with fibroblasts in fibrin and collagen 
constructs reported alterations in cell proliferation, contraction and 
elastic modulus [24]. A lower cell number led to less contraction and 
mechanical strength of the constructs. Co-culture of keratinocytes and 
fibroblasts in fibrin gel increased the keratinocyte number [25]. 
In the present study, the collagen slope and the stiffness of the PRFM 
showed no differences when cultured with or without cells, although 
the collagen slope was slightly higher for the hBM-MSC seeded than 
for the hUC-MSC seeded and unseeded PRFM groups (107.87±49.9 
MPa vs 41.934±31.33 MPa and 54.79±50.37 MPa, respectively). 
When aligned with the collagen slope, the PRFM matrix seeded with 
hBM-MSC showed a slightly greater stiffness when compared with 
the hUC-MSC seeded and unseeded PRFM (120.29±42.46 MPa vs 
47.45±29.29 MPa and 57.79±60.92 MPa, respectively). This lack of a 
difference indicated that the cells in the PRFM had not yet generated 
ECM after 24 h incubation, as collagen is the main fibre that directs 
the tensile strength [26]. The failure to find a difference may also 
reflect the analysis of too small a number of samples in each group, 
as the deviation in each analysis was very broad.  
The findings in this study contrast with previous reports of an 
enhancement of matrix strength by cells embedded in a fibrin gel 
due to myosin-driven cell contraction [27]. One possible explanation 
is that the cells in the PRFM occupied only the matrix surface after 
24 h, and had not yet penetrated the whole matrix. A 
hematoxylin/eosin (H and E) staining study should be conducted to 
investigate this. Another possibility is that static incubation 
precludes the mechanical sensing necessary for the regeneration 
process. Fibroblasts are believed to perceive mechanical loading 
signals from cellular biological events via the cytoskeleton, and the 
signals are transferred and converted in the nucleus to initiated 
expression of ECM components, such as collagen [28]. For example, 
cyclic strains increase collagen synthesis in tendons via this 
mechanism [29]. This possibility will require further studies 
involving collagen quantification and mRNA expression.  
Matrix stiffness directs the differentiation of MSC. For example, 
incubation of UC-MSC with polyacrylamide gels coated with 
fibronectin with differing stiffness (Young's modulus: 13–16 kPa, 35–
38 kPa, 48–53 kPa and 62–68 kPa) resulted in adipogenesis at low 
stiffness and increases in myogenicity markers (e. g. desmin and 
MOYG) at higher stiffness (48–53 kPa) (p<0.05). The stiffest matrix 
drove MSC differentiation into osteogenesis, via the expression of ALP, 
collagen type I, osteocalcin and Runx2 [30]. In the present study, a 
layer of cells was detected on the surface of the PRFM using SEM, and 
the surface showed a gradual thickening. Direct seeding of hBM-MSC 
and hUC-MSC increased the foggy appearance of the cell layer at the 
surface of the PRFM, as indicated by SEM imaging. This might be 
evidence of thickening of the cell layer on the surface of PRFM. 
CONCLUSION 
The stiffness of the PRFM was significantly improved by incubation with 
hBM-MSCs or hUC-MSCs. Although the matrix degradation was very 
high, PRFM showed favorable potential as a vehicle for hBM-MSC 
administration to facilitate wound healing. Further study is needed to 
improve matrix integrity for the application of PRFM as a scaffold. 
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